The possibilities of ultrasound imaging in the diagnosis of follicular neoplasia of the thyroid gland-Reference-Cited by-同舟云学术

The possibilities of ultrasound imaging in the diagnosis of follicular neoplasia of the thyroid gland

Published:2023-06-01 Issue:1 Volume:13 Page:81-90
ISSN:2411-4634
Container-title:Head and Neck Tumors (HNT)
language:
Short-container-title:Opuholi golovy i šei

Author:

Dolidze D. D.¹^ORCID,Bagatelia Z. A.¹^ORCID,Lukin A. Yu.¹^ORCID,Сovantsev S. D.²^ORCID,Shevyakova T. V.²^ORCID,Pichugina N. V.²^ORCID,Skripnichenko D. M.²,Mulaeva K. A.³^ORCID

Affiliation:

1. S.P. Botkin City Clinical Hospital, Moscow Healthcare Department; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

2. S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

3. Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Abstract

Thyroid cancer is the most common cancer of the endocrine system. The diagnosis of thyroid cancer has taken a step forward due to the introduction of fine-needle biopsy of the thyroid gland with subsequent evaluation of cytological material using the Bethesda system. One category of this classification traditionally remains a gray area of diagnosis. The detection of a follicular tumor in the cytological material (category IV according to Bethesda) does not allow one to reliably classify the neoplasia as benign or malignant and requires surgical intervention. The traditional informative and widely used method for diagnosing thyroid tumors is ultrasound. However, the sensitivity and specificity of the method varies over a wide range. This review analyzes the literature on the possibilities of ultrasound diagnostics in assessing the malignant potential of follicular tumors of the thyroid gland.

Publisher

Publishing House ABV Press

Subject

Pharmacology (medical),Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Otorhinolaryngology,Surgery

Reference44 articles.

1. Поляков А.П., Мордовский А.В., Никифорович П.А. и др. Клинические наблюдения эффективности терапии метастатического радиойодрефрактерного высокодифференцированного рака щитовидной железы мультикиназными ингибиторами. Эндокринная хирургия 2018;12(2):81–8. DOI: 10.14341/serg9614 Polyakov A.P., Mordovsky A.V., Nikiforovich P.A. et al. Clinical observations of the effectiveness of therapy of metastatic radioiodrefract highly differentiated thyroid cancer with multikinase inhibitors. Ehndokrinnaya khirurgiya = Endocrine Surgery 2018;12(2):81–8. DOI: 10.14341/serg961

2. Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clini 2021;71(3):209–49. DOI: 10.3322/caac.21660

3. De Crea C., Raffaelli M., Sessa L. et al. Actual incidence and clinical behaviour of follicular thyroid carcinoma: an institutional experience. Scientific World Journal 2014;2014:952095. DOI: 10.1155/2014/952095

4. WHO classification of tumours of endocrine organs. 4th edn. Ed. by R.V. Lloyd, R.Y. Osamura, G. Kloppel, J. Rosai. 2017. Available at: https://publications.iarc.fr/Book-And-Report-Series/ Who-Classification-Of-Tumours/WHO-Classification-OfTumours-Of-Endocrine-Organs-2017.

5. Cibas E.S., Ali S.Z. The 2017 Bethesda System for reporting thyroid cytopathology. Thyroid 2017;27(11):1341–6. DOI: 10.1089/ thy.2017.0500